FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006571769> ?p ?o ?g. }

• W3006571769 endingPage "278" @default.
• W3006571769 startingPage "268" @default.
• W3006571769 abstract "There is an inter-relationship between thrombosis and inflammation. Previously, we have shown the importance of P-selectin in thrombogenesis and thrombus resolution in many preclinical animal models. The role of E-selectin has been explored in rodent models and in a small pilot study of clinical calf vein deep venous thrombosis. The purpose of this study was to determine the role of E-selectin in thrombosis in a primate model of proximal iliac vein thrombosis, a model close to the human condition.Iliac vein thrombosis was induced with a well-characterized primate model. Through a transplant incision, the hypogastric vein and iliac vein branches were ligated. Thrombus was induced by balloon occlusion of the proximal and distal iliac vein for 6 hours. The balloons were then deflated, and the primates recovered. Starting on postocclusion day 2, animals were treated with the E-selectin inhibitor GMI-1271, 25 mg/kg subcutaneously, once daily until day 21 (n = 4). Nontreated control animals received no treatment (n = 5). All animals were evaluated by magnetic resonance venography (MRV); evaluation of vessel area by ultrasound, protein analysis, hematology (complete blood count), and coagulation tests (bleeding time, prothrombin time, activated partial thromboplastin time, fibrinogen, and thromboelastography) were performed at baseline, day 2, day 7, day 14, and day 21 with euthanasia. In addition, platelet function and CD44 expression on leukocytes were determined.E-selectin inhibition by GMI-1271 significantly increased vein recanalization by MRV vs control animals on day 14 (P < .05) and day 21 (P < .0001). GMI-1271 significantly decreased vein wall inflammation by MRV with gadolinium vein wall enhancement vs control also on day 14 (P < .0001) and day 21 (P < .0001). The thromboelastographic measure of clot strength (maximum amplitude) showed significant decreases in animals treated with GMI-1271 vs controls at day 2 (P < .05) and day 7 (P < .05). Animals treated with GMI-1271 had significant vessel area increase by day 21 vs controls (P < .05) by ultrasound. Vein wall intimal thickening (P < .001) and intimal fibrosis (P < .05) scores were significantly decreased in GMI-1271-treated animals vs controls. Importantly, no significant differences in hematology or coagulation test results were noted between all groups, suggesting that E-selectin inhibition carries no bleeding potential. GMI-1271 did not affect platelet function or aggregation or CD44 expression on leukocytes. In addition, no episodes of bleeding were noted in either group.This study suggests that E-selectin modulates venous thrombus progression and that its inhibition will increase thrombus recanalization and decrease vein wall inflammation, without affecting coagulation. The use of an E-selectin inhibitor such as GMI-1271 could potentially change how we treat deep venous thrombosis." @default.
• W3006571769 created "2020-02-24" @default.
• W3006571769 creator A5004151065 @default.
• W3006571769 creator A5009201287 @default.
• W3006571769 creator A5011074312 @default.
• W3006571769 creator A5011637216 @default.
• W3006571769 creator A5026350592 @default.
• W3006571769 creator A5035729247 @default.
• W3006571769 creator A5039752670 @default.
• W3006571769 creator A5040266544 @default.
• W3006571769 creator A5040831611 @default.
• W3006571769 creator A5053954784 @default.
• W3006571769 creator A5054173938 @default.
• W3006571769 creator A5060926574 @default.
• W3006571769 creator A5075997575 @default.
• W3006571769 creator A5085977410 @default.
• W3006571769 creator A5088764798 @default.
• W3006571769 date "2020-03-01" @default.
• W3006571769 modified "2023-10-13" @default.
• W3006571769 title "A new way to treat proximal deep venous thrombosis using E-selectin inhibition" @default.
• W3006571769 cites W118180966 @default.
• W3006571769 cites W1598671158 @default.
• W3006571769 cites W1965086435 @default.
• W3006571769 cites W1986747192 @default.
• W3006571769 cites W1988976281 @default.
• W3006571769 cites W1995059268 @default.
• W3006571769 cites W2003384828 @default.
• W3006571769 cites W2004690648 @default.
• W3006571769 cites W2010184579 @default.
• W3006571769 cites W2011751614 @default.
• W3006571769 cites W2032319834 @default.
• W3006571769 cites W2035055513 @default.
• W3006571769 cites W2053608887 @default.
• W3006571769 cites W2055563833 @default.
• W3006571769 cites W2064973550 @default.
• W3006571769 cites W2086708696 @default.
• W3006571769 cites W2123891436 @default.
• W3006571769 cites W2137744809 @default.
• W3006571769 cites W2145097136 @default.
• W3006571769 cites W2152914954 @default.
• W3006571769 cites W2160763314 @default.
• W3006571769 cites W2161349379 @default.
• W3006571769 cites W2242893540 @default.
• W3006571769 cites W2289409406 @default.
• W3006571769 cites W2408870504 @default.
• W3006571769 cites W2418890452 @default.
• W3006571769 cites W2595533414 @default.
• W3006571769 cites W4230743743 @default.
• W3006571769 cites W54197995 @default.
• W3006571769 cites W2803855730 @default.
• W3006571769 doi "https://doi.org/10.1016/j.jvsv.2019.08.016" @default.
• W3006571769 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32067728" @default.
• W3006571769 hasPublicationYear "2020" @default.
• W3006571769 type Work @default.
• W3006571769 sameAs 3006571769 @default.
• W3006571769 citedByCount "9" @default.
• W3006571769 countsByYear W30065717692020 @default.
• W3006571769 countsByYear W30065717692021 @default.
• W3006571769 countsByYear W30065717692022 @default.
• W3006571769 countsByYear W30065717692023 @default.
• W3006571769 crossrefType "journal-article" @default.
• W3006571769 hasAuthorship W3006571769A5004151065 @default.
• W3006571769 hasAuthorship W3006571769A5009201287 @default.
• W3006571769 hasAuthorship W3006571769A5011074312 @default.
• W3006571769 hasAuthorship W3006571769A5011637216 @default.
• W3006571769 hasAuthorship W3006571769A5026350592 @default.
• W3006571769 hasAuthorship W3006571769A5035729247 @default.
• W3006571769 hasAuthorship W3006571769A5039752670 @default.
• W3006571769 hasAuthorship W3006571769A5040266544 @default.
• W3006571769 hasAuthorship W3006571769A5040831611 @default.
• W3006571769 hasAuthorship W3006571769A5053954784 @default.
• W3006571769 hasAuthorship W3006571769A5054173938 @default.
• W3006571769 hasAuthorship W3006571769A5060926574 @default.
• W3006571769 hasAuthorship W3006571769A5075997575 @default.
• W3006571769 hasAuthorship W3006571769A5085977410 @default.
• W3006571769 hasAuthorship W3006571769A5088764798 @default.
• W3006571769 hasBestOaLocation W30065717692 @default.
• W3006571769 hasConcept C126322002 @default.
• W3006571769 hasConcept C126894567 @default.
• W3006571769 hasConcept C141071460 @default.
• W3006571769 hasConcept C2777202286 @default.
• W3006571769 hasConcept C2777664302 @default.
• W3006571769 hasConcept C2778261982 @default.
• W3006571769 hasConcept C2778959117 @default.
• W3006571769 hasConcept C2779216453 @default.
• W3006571769 hasConcept C2780868729 @default.
• W3006571769 hasConcept C2781362458 @default.
• W3006571769 hasConcept C2993802102 @default.
• W3006571769 hasConcept C71924100 @default.
• W3006571769 hasConcept C89560881 @default.
• W3006571769 hasConceptScore W3006571769C126322002 @default.
• W3006571769 hasConceptScore W3006571769C126894567 @default.
• W3006571769 hasConceptScore W3006571769C141071460 @default.
• W3006571769 hasConceptScore W3006571769C2777202286 @default.
• W3006571769 hasConceptScore W3006571769C2777664302 @default.
• W3006571769 hasConceptScore W3006571769C2778261982 @default.
• W3006571769 hasConceptScore W3006571769C2778959117 @default.
• W3006571769 hasConceptScore W3006571769C2779216453 @default.

• next